FindTrial
Sign In

Outcomes and quality of life in patients with locally advanced cancers of vulva and vagina.

Clinical outcomes and quality of life in patients with locally advanced vulvovaginal cancers: ambispective registration study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039262
Enrollment
200
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C52- Malignant neoplasm of vagina Health Condition 2: C519- Malignant neoplasm of vulva, unspecified

Interventions

None listed

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with vulvo-vaginal cancer. 2. Patients treated with Radiation+/- chemotherapy +/- surgery from January 1, 2019- December 31, 2023.

Exclusion criteria

Exclusion criteria: 1. Patients with Metastatic disease at the presentation. 2. Incomplete information on the EMR.

Design outcomes

Primary

MeasureTime frame
To report patterns of relapse and disease outcomes in patients with vulvovaginal cancer treated with radiation (+/- chemotherapy): RFS, DFSTimepoint: 3 Years—

Secondary

MeasureTime frame
To report on acute and late effect of treatment outcomes using CTCAE.Timepoint: 5 Years;To report on longitudinal QOL using EORTC QLQ C-30 and VU-34 (English, Hindi, Marathi as applicable)Timepoint: 4,8,12,16,20,24,30,36,42,48, 54,60 months;To report outcomes as a function of p16, AKT, PDL-1 expression.Timepoint: 5 Years—

Countries

India

Contacts

Public ContactDr Priyanshu Tripathi

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

supriyasastri@gmail.com9930958309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026